NSE · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at 115.10 against a street estimate of 60.01 — a beat of 91.8%.
with an average price target of ₹24,334.75.
| Document | Date |
|---|---|
| Q1 FY27 earnings call NEULAND LABORATORIES LIMITED – Q1 FY27 EARNINGS SUMMARY HEADLINE NUMBERS • Total Income: INR 650.1 crores (Q1 FY27) vs INR 300.6 crores (Q1 FY26) – | 2026-08-10 |
| Investor presentation · Q1 FY27 NEULAND LABORATORIES LIMITED – Q1 FY27 INVESTOR SUMMARY --- HEADLINE NUMBERS • Total Income Q1FY27: Rs. 650.1 crore (116.3% YoY growth; down 17.6% | 2026-08-05 |
| Quarterly results · Q1 FY27 NEULAND LABORATORIES LIMITED – Q1 FY27 FINANCIAL SUMMARY HEADLINE NUMBERS • Total Income: Rs. 650.1 crore in Q1 FY27, up 116.3% year-on-year from Rs | 2026-08-05 |
| Annual report FY2026 NEULAND LABORATORIES LIMITED - FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue milestone: Company crossed ₹1,000 crore in previous year; FY 2025-26 sa | 2026-07-09 |
| Q4 FY26 earnings call NEULAND LABORATORIES LIMITED – Q4 & FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Q4 FY26 Revenue: INR 788.7 crores, up 134.9% YoY (vs INR 335.8 crores i | 2026-05-16 |
| Quarterly results · Q4 FY26 NEULAND LABORATORIES LIMITED – SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Annual Revenue (FY 2025-26): Rs. 2,02,298.54 lakhs (consolidated), up | 2026-05-12 |
| Investor presentation · Q4 FY26 NEULAND LABORATORIES LIMITED – INVESTOR SUMMARY Q4FY26 & FY26 Results (May 12, 2026) --- HEADLINE NUMBERS • Total Income FY26: Rs. 2,053.1 crore (3 | 2026-05-12 |
| Q3 FY26 earnings call NEULAND LABORATORIES LIMITED – Q3 FY26 SUMMARY HEADLINE NUMBERS • Q3 FY26 Total Income: INR 447.8 crores, up 11.4% YoY (vs INR 401.9 crores in Q3 FY | 2026-02-13 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹34 / share ex-date Jul 24, 2026 | 2026-07-24 |
| Announcement | Date |
|---|---|
| Enhancement of manufacturing capacity announced Disclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity | 2026-08-05 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Neuland Laboratories Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.